Biogen Inc.

Biogen Inc.verified

BIIB

Price:

$173.52

Market Cap:

$25.29B

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of AN...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1991-09-17

Stock Exchange

NASDAQ

Ticker

BIIB

The Enterprise Value as of November 2024 (TTM) for Biogen Inc. (BIIB) is 28.49B

According to Biogen Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 28.49B. This represents a change of -24.52% compared to the average of 37.74B of the last 4 quarters.

Biogen Inc. (BIIB) Historical Enterprise Value (quarterly & annually)

How has BIIB Enterprise Value performed in the past?

The mean historical Enterprise Value of Biogen Inc. over the last ten years is 59.32B. The current 28.49B Enterprise Value has changed 4.70% with respect to the historical average. Over the past ten years (40 quarters), BIIB's Enterprise Value was at its highest in in the March 2015 quarter at 98.33B. The Enterprise Value was at its lowest in in the September 2024 quarter at 31.43B.

Quarterly (TTM)
Annual

Average

59.32B

Median

62.55B

Minimum

41.11B

Maximum

79.61B

Biogen Inc. (BIIB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Biogen Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 20.21%

Maximum Annual Enterprise Value = 79.61B

Minimum Annual Increase = -22.17%

Minimum Annual Enterprise Value = 41.11B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202343.73B0.69%
202243.43B5.64%
202141.11B-10.42%
202045.89B-22.17%
201958.97B-11.15%
201866.37B-7.93%
201772.09B9.03%
201666.12B-12.87%
201575.89B-4.68%
201479.61B20.21%

Biogen Inc. (BIIB) Average Enterprise Value

How has BIIB Enterprise Value performed in the past?

The current Enterprise Value of Biogen Inc. (BIIB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

42.76B

5-year avg

46.63B

10-year avg

59.32B

Biogen Inc. (BIIB) Enterprise Value vs. Peers

How is BIIB’s Enterprise Value compared to its peers?

Biogen Inc.’s Enterprise Value is less than Bristol-Myers Squibb Company (154.32B), less than AbbVie Inc. (411.60B), less than Merck & Co., Inc. (284.66B), less than Gilead Sciences, Inc. (132.43B), less than Johnson & Johnson (396.75B), less than Amgen Inc. (221.74B), less than Pfizer Inc. (225.71B), less than Sanofi (138.88B), less than Novartis AG (232.94B), less than GSK plc (54.90B),

CompanyEnterprise ValueMarket cap
154.32B$112.46B
411.60B$354.10B
284.66B$258.22B
132.43B$111.85B
396.75B$380.98B
221.74B$170.35B
225.71B$157.31B
138.88B$132.76B
232.94B$216.23B
54.90B$75.40B

Build a custom stock screener for Biogen Inc. (BIIB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biogen Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Biogen Inc. (BIIB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Biogen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Biogen Inc.'s Enterprise Value?

What is the highest Enterprise Value for Biogen Inc. (BIIB)?

What is the 3-year average Enterprise Value for Biogen Inc. (BIIB)?

What is the 5-year average Enterprise Value for Biogen Inc. (BIIB)?

How does the current Enterprise Value for Biogen Inc. (BIIB) compare to its historical average?